Spots Global Cancer Trial Database for limited stage small cell lung cancer
Every month we try and update this database with for limited stage small cell lung cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer | NCT00003364 | Lung Cancer | cisplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... radiation thera... | - 74 Years | National Cancer Institute (NCI) | |
| Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small Cell Lung Cancer : A Phase 2 Trial | NCT06256237 | Limited Stage S... | JS004 Toripalimab surgery Etoposide Platinum | 18 Years - | Shanghai Pulmonary Hospital, Shanghai, China | |
| Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy | NCT00004249 | Lung Cancer | QS21 keyhole limpet ... polysialic acid | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer | NCT05496166 | Limited Stage S... | chemotherapy an... | 18 Years - 70 Years | Shanghai Pulmonary Hospital, Shanghai, China | |
| VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer | NCT00282022 | Lung Cancer | laromustine | 18 Years - | National Cancer Institute (NCI) | |
| VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer | NCT00282022 | Lung Cancer | laromustine | 18 Years - | National Cancer Institute (NCI) | |
| Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung Cancer | NCT00062322 | Lung Cancer | cisplatin irinotecan hydr... conventional su... neoadjuvant the... radiation thera... | 18 Years - | Fox Chase Cancer Center | |
| S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer | NCT00006487 | Lung Cancer | cisplatin etoposide tirapazamine radiation thera... | 18 Years - | SWOG Cancer Research Network | |
| Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery | NCT00020007 | Lung Cancer Metastatic Canc... | isolated perfus... paclitaxel hyperthermia tr... | 18 Years - | National Cancer Institute (NCI) | |
| Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer | NCT00061919 | Lung Cancer | Carboplatin, et... Carboplatin, et... | 18 Years - | University College, London | |
| Dalteparin in Preventing Blood Clots in Patients With Lung Cancer | NCT00519805 | Lung Cancer Thromboembolism | dalteparin quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | NCT00006012 | Drug/Agent Toxi... Lung Cancer Radiation Toxic... | filgrastim amifostine trih... cisplatin etoposide paclitaxel topotecan hydro... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line Chemoradiotherapy | NCT04829708 | Limited Stage S... | MRI Surveillanc... Prophylactic Cr... | 18 Years - 75 Years | Shandong Cancer Hospital and Institute | |
| Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer | NCT00002822 | Lung Cancer | carboplatin cisplatin cyclophosphamid... doxorubicin hyd... etoposide ifosfamide mesna vincristine sul... radiation thera... | - | National Cancer Institute (NCI) | |
| ZD6474 in Treating Patients With Small Cell Lung Cancer | NCT00066313 | Lung Cancer | vandetanib adjuvant therap... | 16 Years - 120 Years | Sanofi | |
| Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer | NCT00019201 | Head and Neck C... Lung Cancer | cytology specim... immunohistochem... sputum cytology bronchoscopic a... bronchoscopy comparison of s... endoscopic biop... | 18 Years - | National Cancer Institute (NCI) | |
| S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung Cancer | NCT00090961 | Lung Cancer Pulmonary Compl... | educational int... supervised exer... | - | SWOG Cancer Research Network | |
| Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung Cancer | NCT00433498 | Lung Cancer | carboplatin cisplatin etoposide phosp... pravastatin sod... | 18 Years - | University College, London | |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | NCT00033696 | Lung Cancer | filgrastim carboplatin etoposide paclitaxel topotecan hydro... radiation thera... | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer | NCT00897793 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Prostate Cancer | venipuncture radiation thera... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | NCT00387699 | Lung Cancer | bevacizumab cisplatin etoposide radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer | NCT01457469 | Limited Stage S... Recurrent Small... Stage IA Non-sm... Stage IB Non-sm... Stage IIA Non-s... Stage IIB Non-s... Stage IIIA Non-... Stage IIIB Non-... Tobacco Use Dis... | questionnaire a... quality-of-life... counseling inte... internet-based ... telephone-based... educational int... nicotine replac... educational int... | 18 Years - | Wake Forest University Health Sciences | |
| PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study) | NCT04790253 | Limited Stage S... Extensive-stage... | Prophylactic cr... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors | NCT00433407 | Breast Cancer Lung Cancer Ovarian Cancer Prostate Cancer Sarcoma Unspecified Adu... | trastuzumab | - | Jonsson Comprehensive Cancer Center | |
| Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung Cancer | NCT00433498 | Lung Cancer | carboplatin cisplatin etoposide phosp... pravastatin sod... | 18 Years - | University College, London | |
| Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer | NCT00004186 | Lung Cancer | carboplatin etoposide ifosfamide topotecan hydro... radiation thera... | - | University of Alabama at Birmingham | |
| PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer | NCT00544674 | Lung Cancer | PR104 F-18-fluoromiso... | 18 Years - | Proacta, Incorporated | |
| Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery | NCT00303901 | Lung Cancer Metastatic Canc... | cryosurgery positron emissi... | 18 Years - 120 Years | Barbara Ann Karmanos Cancer Institute | |
| Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer | NCT00066742 | Limited Stage S... | tirapazamine cisplatin etoposide radiation thera... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer | NCT00005022 | Lung Cancer | cisplatin etoposide radiation thera... | 18 Years - 80 Years | Radiation Therapy Oncology Group | |
| Radiation Therapy in Preventing Brain Metastases in Patients With Small Cell Lung Cancer | NCT00006344 | Lung Cancer | radiation thera... | - | Virginia Commonwealth University | |
| Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer | NCT00004186 | Lung Cancer | carboplatin etoposide ifosfamide topotecan hydro... radiation thera... | - | University of Alabama at Birmingham | |
| Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers | NCT01935336 | Adenocarcinoma ... Extensive Stage... Limited Stage S... Recurrent Non-s... Recurrent Small... Stage IIIA Non-... Stage IIIB Non-... Stage IV Non-sm... | Ponatinib | 18 Years - | University of Colorado, Denver | |
| Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer | NCT00031785 | Anorexia Cachexia Lung Cancer | megestrol aceta... radiation thera... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer | NCT00470054 | Extensive Stage... Limited Stage S... Recurrent Small... | dasatinib | 18 Years - | National Cancer Institute (NCI) | |
| Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT | NCT05623267 | Limited Stage S... | Sugemalimab Placebo | 18 Years - | Sun Yat-sen University | |
| Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | NCT00059761 | Lung Cancer | cisplatin irinotecan hydr... radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
| Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer | NCT00009971 | Lung Cancer | fenretinide | 18 Years - | National Cancer Institute (NCI) | |
| Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer | NCT00057746 | Lung Cancer | Prophylactic cr... Prophylactic cr... Prophylactic cr... | - 120 Years | Radiation Therapy Oncology Group | |
| Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers | NCT01935336 | Adenocarcinoma ... Extensive Stage... Limited Stage S... Recurrent Non-s... Recurrent Small... Stage IIIA Non-... Stage IIIB Non-... Stage IV Non-sm... | Ponatinib | 18 Years - | University of Colorado, Denver | |
| Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer | NCT00900835 | Breast Cancer Colorectal Canc... Fatigue Lung Cancer Pain Prostate Cancer | educational int... questionnaire a... study of socioe... assessment of t... fatigue assessm... quality-of-life... standard follow... | 18 Years - | City of Hope Medical Center | |
| Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung Cancer | NCT00416689 | Breast Cancer Lung Cancer Nausea and Vomi... | assessment of t... quality-of-life... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Durvalumab With Chemotherapy Followed by Sequential Radiotherapy for Limited Stage Small Cell Lung Cancer | NCT05034133 | Limited Stage S... | Durvalumab | 18 Years - | Beijing Haidian Hospital | |
| Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | NCT00004176 | Drug/Agent Toxi... Lung Cancer Radiation Toxic... | amifostine trih... cisplatin etoposide radiation thera... | 18 Years - | Washington University School of Medicine | |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | NCT00033696 | Lung Cancer | filgrastim carboplatin etoposide paclitaxel topotecan hydro... radiation thera... | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer | NCT01262560 | Dysphagia Lung Cancer Pain Esophagitis | Manuka honey in... Manuka honey in... Standard suppor... | 18 Years - | Radiation Therapy Oncology Group | |
| Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery | NCT00303901 | Lung Cancer Metastatic Canc... | cryosurgery positron emissi... | 18 Years - 120 Years | Barbara Ann Karmanos Cancer Institute | |
| Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer | NCT00005071 | Lung Cancer | biopsy bronchoscopy computed tomogr... quality-of-life... | - | National Cancer Institute (NCI) | |
| Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy | NCT00004249 | Lung Cancer | QS21 keyhole limpet ... polysialic acid | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Pamiparib for Consolidation Treatment of Unprogressed LS-SCLC After Concurrent Chemoradiotherapy | NCT05483543 | Limited Stage S... | Pamiparib | 18 Years - | Fudan University | |
| Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease | NCT02046733 | Limited Stage S... Small Cell Lung... | Ipilimumab Nivolumab | 18 Years - | ETOP IBCSG Partners Foundation | |
| Liposomal SN-38 in Treating Patients With Small Cell Lung Cancer | NCT00104754 | Lung Cancer | liposomal SN-38 | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors | NCT00078845 | Breast Cancer Lung Cancer Neurotoxicity Ovarian Cancer Prostate Cancer Unspecified Adu... | Amifostine | 18 Years - | M.D. Anderson Cancer Center | |
| Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy | NCT00084487 | Extensive Stage... Limited Stage S... Recurrent Small... | becatecarin | 18 Years - | National Cancer Institute (NCI) | |
| Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung Cancer | NCT00014066 | Lung Cancer | hematoporphyrin... brachytherapy | 18 Years - | Roswell Park Cancer Institute | |
| S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung Cancer | NCT00090961 | Lung Cancer Pulmonary Compl... | educational int... supervised exer... | - | SWOG Cancer Research Network | |
| Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer | NCT00005022 | Lung Cancer | cisplatin etoposide radiation thera... | 18 Years - 80 Years | Radiation Therapy Oncology Group | |
| S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer | NCT00006487 | Lung Cancer | cisplatin etoposide tirapazamine radiation thera... | 18 Years - | SWOG Cancer Research Network | |
| Family Quality of Life Among Families With a Member Who is a Cancer Patient | NCT00544336 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Prostate Cancer Solid Tumor | questionnaire a... survey administ... quality-of-life... | 21 Years - | Vanderbilt-Ingram Cancer Center | |
| Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT | NCT05623267 | Limited Stage S... | Sugemalimab Placebo | 18 Years - | Sun Yat-sen University | |
| S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride | NCT01416688 | Colorectal Canc... Dermatologic Co... Lung Cancer Therapy-related... | assessment of t... psychosocial as... quality-of-life... | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | NCT00066222 | Lung Cancer | Cisplatin Etoposide Radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
| Liposomal SN-38 in Treating Patients With Small Cell Lung Cancer | NCT00104754 | Lung Cancer | liposomal SN-38 | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Durvalumab With Chemotherapy Followed by Sequential Radiotherapy for Limited Stage Small Cell Lung Cancer | NCT05034133 | Limited Stage S... | Durvalumab | 18 Years - | Beijing Haidian Hospital | |
| Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer | NCT00003329 | Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer | gene mapping | 0 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer | NCT00002858 | Lung Cancer | cisplatin cyclophosphamid... doxorubicin hyd... etoposide radiation thera... | - 69 Years | National Cancer Institute (NCI) | |
| S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer | NCT00045617 | Lung Cancer | monoclonal anti... monoclonal anti... cisplatin etoposide radiation thera... | 18 Years - | SWOG Cancer Research Network | |
| Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer | NCT00003329 | Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer | gene mapping | 0 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer | NCT00372840 | Breast Cancer Colorectal Canc... Lung Cancer Malignant Mesot... Prostate Cancer Psychosocial Ef... Thymoma and Thy... | educational int... psychosocial as... quality-of-life... | 18 Years - 120 Years | Fox Chase Cancer Center | |
| Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT | NCT05623267 | Limited Stage S... | Sugemalimab Placebo | 18 Years - | Sun Yat-sen University | |
| Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery | NCT00303901 | Lung Cancer Metastatic Canc... | cryosurgery positron emissi... | 18 Years - 120 Years | Barbara Ann Karmanos Cancer Institute | |
| Radiation Therapy in Preventing Brain Metastases in Patients With Small Cell Lung Cancer | NCT00006344 | Lung Cancer | radiation thera... | - | Virginia Commonwealth University | |
| Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung Cancer | NCT00416689 | Breast Cancer Lung Cancer Nausea and Vomi... | assessment of t... quality-of-life... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer | NCT00282022 | Lung Cancer | laromustine | 18 Years - | National Cancer Institute (NCI) | |
| Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region | NCT00693836 | Lung Cancer | genetic linkage... loss of heteroz... mutation analys... polymerase chai... polymorphism an... biologic sample... medical chart r... questionnaire a... evaluation of c... | 18 Years - | National Cancer Institute (NCI) | |
| Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer | NCT00003583 | Drug/Agent Toxi... Lung Cancer Radiation Toxic... | amifostine trih... cisplatin etoposide radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | NCT00066222 | Lung Cancer | Cisplatin Etoposide Radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
| Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | NCT00072527 | Lung Cancer | carboplatin cisplatin etoposide irinotecan hydr... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer | NCT00005022 | Lung Cancer | cisplatin etoposide radiation thera... | 18 Years - 80 Years | Radiation Therapy Oncology Group | |
| Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | NCT00059761 | Lung Cancer | cisplatin irinotecan hydr... radiation thera... | 18 Years - | Radiation Therapy Oncology Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
